Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906397648> ?p ?o ?g. }
- W2906397648 endingPage "623" @default.
- W2906397648 startingPage "602" @default.
- W2906397648 abstract "Aberrant expression of eukaryotic translation initiation factor 4E (eIF4E) is common in many types of cancer including acute myeloid leukaemia (AML). Phosphorylation of eIF4E by MAPK-interacting kinases (Mnks) is essential for the eIF4E-mediated oncogenic activity. As such, the pharmacological inhibition of Mnks can be an effective strategy for the treatment of cancer.A series of N-phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine derivatives was designed and synthesised. The Mnk inhibitory activity of these derivatives as well as their anti-proliferative activity against MV4-11 AML cells was determined.These compounds were identified as potent Mnk2 inhibitors. Most of them demonstrated potent anti-proliferative activity against MV4-11 AML cells. The cellular mechanistic studies of the representative inhibitors revealed that they reduced the level of phosphorylated eIF4E and induced apoptosis by down-regulating the anti-apoptotic protein myeloid cell leukaemia 1 (Mcl-1) and by cleaving poly(ADP-ribose)polymerase (PARP). The lead compound 7k possessed desirable pharmacokinetic properties and oral bioavailability.This work proposes that exploration of the structural diversity in the context of Nphenyl- 4-(1H-pyrrol-3-yl)pyrimidin-2-amine would offer potent and selective Mnk inhibitors." @default.
- W2906397648 created "2019-01-01" @default.
- W2906397648 creator A5002750621 @default.
- W2906397648 creator A5005390105 @default.
- W2906397648 creator A5011817296 @default.
- W2906397648 creator A5023170050 @default.
- W2906397648 creator A5030623527 @default.
- W2906397648 creator A5042380073 @default.
- W2906397648 creator A5043419710 @default.
- W2906397648 creator A5070160143 @default.
- W2906397648 creator A5071458554 @default.
- W2906397648 creator A5076511286 @default.
- W2906397648 creator A5076737013 @default.
- W2906397648 creator A5082938857 @default.
- W2906397648 creator A5084930762 @default.
- W2906397648 date "2019-01-01" @default.
- W2906397648 modified "2023-10-01" @default.
- W2906397648 title "Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity." @default.
- W2906397648 cites W1455253142 @default.
- W2906397648 cites W1516043257 @default.
- W2906397648 cites W1787974493 @default.
- W2906397648 cites W1972648122 @default.
- W2906397648 cites W1974404622 @default.
- W2906397648 cites W1976198410 @default.
- W2906397648 cites W1986308117 @default.
- W2906397648 cites W1987835529 @default.
- W2906397648 cites W2005234434 @default.
- W2906397648 cites W2005699415 @default.
- W2906397648 cites W2008669399 @default.
- W2906397648 cites W2010217335 @default.
- W2906397648 cites W2013256082 @default.
- W2906397648 cites W2015183783 @default.
- W2906397648 cites W2016365699 @default.
- W2906397648 cites W2018054166 @default.
- W2906397648 cites W2025565532 @default.
- W2906397648 cites W2031216046 @default.
- W2906397648 cites W2032666422 @default.
- W2906397648 cites W2034132874 @default.
- W2906397648 cites W2034713747 @default.
- W2906397648 cites W2036299413 @default.
- W2906397648 cites W2037712095 @default.
- W2906397648 cites W2038146634 @default.
- W2906397648 cites W2040885133 @default.
- W2906397648 cites W2049099625 @default.
- W2906397648 cites W2055075141 @default.
- W2906397648 cites W2058586971 @default.
- W2906397648 cites W2069641384 @default.
- W2906397648 cites W2071111320 @default.
- W2906397648 cites W2075420263 @default.
- W2906397648 cites W2076926270 @default.
- W2906397648 cites W2078218463 @default.
- W2906397648 cites W2078634145 @default.
- W2906397648 cites W2081003976 @default.
- W2906397648 cites W2082834726 @default.
- W2906397648 cites W2086707089 @default.
- W2906397648 cites W2086938346 @default.
- W2906397648 cites W2089020035 @default.
- W2906397648 cites W2102889876 @default.
- W2906397648 cites W2107495112 @default.
- W2906397648 cites W2108430637 @default.
- W2906397648 cites W2111255040 @default.
- W2906397648 cites W2111686163 @default.
- W2906397648 cites W2112519486 @default.
- W2906397648 cites W2121647526 @default.
- W2906397648 cites W2127073449 @default.
- W2906397648 cites W2132519593 @default.
- W2906397648 cites W2149259467 @default.
- W2906397648 cites W2153840558 @default.
- W2906397648 cites W2154584286 @default.
- W2906397648 cites W2155580728 @default.
- W2906397648 cites W2157497892 @default.
- W2906397648 cites W2254118178 @default.
- W2906397648 cites W2282132848 @default.
- W2906397648 cites W2501995810 @default.
- W2906397648 cites W2514159675 @default.
- W2906397648 cites W2520970142 @default.
- W2906397648 cites W2563173215 @default.
- W2906397648 cites W2736416431 @default.
- W2906397648 cites W2736437089 @default.
- W2906397648 cites W2744997844 @default.
- W2906397648 cites W2789484111 @default.
- W2906397648 cites W2793387915 @default.
- W2906397648 cites W3160135466 @default.
- W2906397648 cites W4251347601 @default.
- W2906397648 doi "https://doi.org/10.2174/1573406415666181219111511" @default.
- W2906397648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30569866" @default.
- W2906397648 hasPublicationYear "2019" @default.
- W2906397648 type Work @default.
- W2906397648 sameAs 2906397648 @default.
- W2906397648 citedByCount "7" @default.
- W2906397648 countsByYear W29063976482020 @default.
- W2906397648 countsByYear W29063976482021 @default.
- W2906397648 countsByYear W29063976482023 @default.
- W2906397648 crossrefType "journal-article" @default.
- W2906397648 hasAuthorship W2906397648A5002750621 @default.
- W2906397648 hasAuthorship W2906397648A5005390105 @default.
- W2906397648 hasAuthorship W2906397648A5011817296 @default.
- W2906397648 hasAuthorship W2906397648A5023170050 @default.